DSIP remains an experimental peptide, with limited clinical trials, no standardized dosing guidelines, and no regulatory approval for medical use
Adverse reactions to GHK-Cu, when they occur, tend to be mild and temporary, resolving on their own over time
Use separate injection sites, use separate syringes, and put several hours between them
These recent studies provide new ideas for future research to investigate the role of different hormones in the maintenance of the ocular surface
The CAS number for Glow Blend is 89030-95-5 (GHK-Cu complex)
A larger follow-up RCT (n=72 older adults) confirmed these findings, additionally demonstrating improvements in gait speed (+0.14 m/s), grip strength, 6-minute walk distance, waist circumference reduction, and systolic blood pressure reduction (Kumar et al., J Gerontol A Biol Sci Med Sci, 2023) [21]